Searched for
API MANUFACTURING
Anupam Rasayan eyes US, Europe pharma push after Bliss deal, one-third revenue from drugsAnupam Rasayan India Ltd anticipates significant growth in its pharmaceutical segment over the next three years. The company expects pharma...- Indian SME pharma firms see shift of orders from China; cost, quality concerns remainSmall and mid-sized Indian pharmaceutical firms are witnessing a shift in orders away from China. As Western buyers diversify their supply ...
- 5 stocks with consistent score improvement and upside potential of up to 32% in 1 year, according to analystsFor the next few weeks, the markets will readjust as business updates, which have started to arrive, and the Q2 earnings numbers roll in. C...
- As ‘world architecture’ changes, Jaishankar calls for middle powers to pool resourcesExternal Affairs Minister S Jaishankar called on emerging and middle powers to pool diplomatic, economic and technological resources as glo...
- These large-, mid- & small-cap stocks can give more than 20% return in 1 year, according to analystsOil prices are still up, and so are bond yields, both in the US and in other major markets. And fresh troubles seem to crop up somewhere or...
- India Mobile Congress turns 10, and the 2026 Edition lands in Delhi this OctoberIndia Mobile Congress 2026 is on from October 7 to 10 at Yashobhoomi, New Delhi. The Department of Telecommunications runs it with COAI. Th...
- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsWhat is needed in the markets these days is realism. Not fear or gloom, but a clear-eyed acceptance of where things actually stand. Realism...
- Inside the deal engine room: VCs and PEs make the case for ERP as a governance variableAt an NTT DATA Business Solutions Pvt. Ltd. India roundtable, a cohort of leading VCs and PE investors argued that the maturity of a compan...
- Steamhouse India wins Rs 311 crore EPC mandate for 300 TPH steam project in Himachal PradeshSteamhouse India Ltd has secured a Rs 311 crore EPC mandate for a 300 TPH common steam and co-generation power plant at the Bulk Drug Park ...
- Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...
- Virtual pharma API firm HRV preparing for IPO, DRHP likely in H1 of 2027: SourcesHRV Pharma CEO Hari Kiran Chereddi says investing in capacity at partner facilities, exploring acquisitions for market access; forecasts Rs...
- Short-term headwinds, long-term calm: 6 mid-cap stocks from different sectors with upside potential of up to 22%This is not the time to expect that every stock you own will do well; or that you will make quick and easy gains. If you are entering the m...
- 5 stocks with consistent score improvement and upside potential of up to 22% in 1 year, according to analystsGiven the current situation both globally and domestically, one can expect more headwinds in the market. There is, on the domestic front, a...
- Aragen steps up investment in complex drug modalities; plans 500 KL new CDMO capacityAragen Life Sciences is increasing investments in complex drug modalities and manufacturing. The company plans to add significant small-mol...
- Hi-Tech Flow Solutions files DHRP for IPO, to raises Rs 300 cr via fresh issueHi-Tech Flow Solutions has filed its DRHP for a Rs 300 crore IPO comprising a fresh issue and offer-for-sale. The company plans capacity ex...
- Dr Reddy's inks pact with Gilead for once-yearly HIV prevention drug lenacapavirDr Reddy's Laboratories and Gilead Sciences have signed a licensing agreement. This pact involves investigational once-yearly lenacapavir f...
- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsAs an investor, what you need to do at this point of time is this: A bit of extra work in terms of stock-picking so that you avoid anxiety ...
- Short-term headwind? Yes. But the structure stays intact: 5 large-cap stocks with upside potential of up to 19%Wise men on the street will tell you it is foolish to try and time the market. And attempting to do so in the midst of a raging war is prob...
- Stocks in news: Tata Group stocks, HDFC Bank, Coforge, HFCL, Sun Pharma and Varun BeveragesOn September 11, Indian stock markets experienced a remarkable bounce back after an initial dip at opening. Key index heavyweights attracte...
- A weekend in New Delhi: At BRICS, Modi and India provided an adroit demonstration of tactically gathering a motley crewThe recent BRICS summit hosted twenty nations, fostering debate and wide interpretation of its joint statement. This gathering served as a ...
Load More
